These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27494301)

  • 1. Community-acquired hyperkalemia in elderly patients: risk factors and clinical outcomes.
    Turgutalp K; Bardak S; Helvacı I; İşgüzar G; Payas E; Demir S; Kıykım A
    Ren Fail; 2016 Oct; 38(9):1405-1412. PubMed ID: 27494301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
    Maddirala S; Khan A; Vincent A; Lau K
    Am J Med Sci; 2008 Oct; 336(4):330-5. PubMed ID: 18854676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of acute kidney injury developing outside the hospital in elderly.
    Turgutalp K; Bardak S; Horoz M; Helvacı I; Demir S; Kiykim AA
    Int Urol Nephrol; 2017 Jan; 49(1):113-121. PubMed ID: 27704319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
    Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
    Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA
    Cardiovasc Ther; 2012 Jun; 30(3):e156-66. PubMed ID: 21883995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Surabenjawong U; Thunpiphat N; Chatsiricharoenkul S; Monsomboon A
    J Med Assoc Thai; 2013 Aug; 96(8):905-10. PubMed ID: 23991595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.
    Thomsen RW; Nicolaisen SK; Hasvold P; Sanchez RG; Pedersen L; Adelborg K; Egstrup K; Egfjord M; Sørensen HT
    Nephrol Dial Transplant; 2018 Sep; 33(9):1610-1620. PubMed ID: 29177463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP;
    Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.
    Vardeny O; Claggett B; Anand I; Rossignol P; Desai AS; Zannad F; Pitt B; Solomon SD;
    Circ Heart Fail; 2014 Jul; 7(4):573-9. PubMed ID: 24812304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of factors causing hyperkalemia.
    Takaichi K; Takemoto F; Ubara Y; Mori Y
    Intern Med; 2007; 46(12):823-9. PubMed ID: 17575373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired hypokalemia in elderly patients: related factors and clinical outcomes.
    Bardak S; Turgutalp K; Koyuncu MB; Harı H; Helvacı I; Ovla D; Horoz M; Demir S; Kıykım A
    Int Urol Nephrol; 2017 Mar; 49(3):483-489. PubMed ID: 28035617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns, causes, and effects of hyperkalemia.
    Kovesdy CP
    Nephrol News Issues; 2016 Apr; 30(4):suppl 4-7. PubMed ID: 27254898
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population-Based Cohort Study.
    Thomsen RW; Nicolaisen SK; Hasvold P; Garcia-Sanchez R; Pedersen L; Adelborg K; Egfjord M; Egstrup K; Sørensen HT
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29789332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients.
    Wozakowska-Kapłon B; Janowska-Molenda I
    Pol Arch Med Wewn; 2009 Mar; 119(3):141-7. PubMed ID: 19514643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study.
    Nash DM; Markle-Reid M; Brimble KS; McArthur E; Roshanov PS; Fink JC; Weir MA; Garg AX
    Nephrol Dial Transplant; 2019 Jul; 34(7):1145-1154. PubMed ID: 31264694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne.
    Plovanich M; Weng QY; Mostaghimi A
    JAMA Dermatol; 2015 Sep; 151(9):941-4. PubMed ID: 25796182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.